« Return to News | CROs/Service Providers

Covance Opens Offices in Seoul, Mumbai

Thursday, December 17, 2009 07:42 AM

Covance recently opened new clinical development offices in Seoul, South Korea, and Mumbai, India, building on the contract research organization’s (CRO) two-decade history in the Asia-Pacific region.

The new and expanded offices will help the CRO meet growing demand for clinical development services in Asia-Pacific. The Seoul office will increase patient access in the region and support Covance’s field-based clinical research associates throughout Asia-Pacific, while the Mumbai office will serve as the CRO’s main support hub for the Indian sub-continent.

The company also expanded its offices in Tokyo, Japan, and Hong Kong, China, to increase service capacity in these countries. The Tokyo office will provide additional room for both clinical development and central laboratory services in the Japanese clinical trial market.

"Our new Asia-Pacific offices support our global expansion strategy, which targets the most qualified investigators and appropriate patient populations in a region that is increasingly important to clinical trials," said Nick Wright, vice president and general manager, clinical development services Asia-Pacific, Covance. "These offices will help us increase our clients' phase II/III clinical trial productivity by providing additional capacity to execute clinical studies with a full range of services."

The year 2009 was a big year for growth in emerging markets at Covance, which opened nine new offices in Asia Pacific, Latin America and Eastern Europe.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

June 17

New CISCRP study finds patient perceptions of trial participation safety, motives greatly improved

PwC: Volume and value of pharma, diagnostics deals soar in first quarter, as CRO sector waits on sidelines

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

June

Operating environment spurs out-of-the-box ideas
High cost, low success rates drive some sponsors to new monitoring, protocol design, patient-centric initiatives

Private equity interest in CROs could lead to more IPOs
Now flush with cash, many PE investors readying to cash out

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

May

INC Research, PPD, inVentiv named top CROs
Yet most CROs slipping in ability to manage site relationships

R&D cuts by sponsors spur more collaboration, innovation
New strategies share pipeline activity costs

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.